Cellular Dynamics International (United States)

Cellular Dynamics International (United States)

Fujifilm Cellular Dynamics, Inc. is a large scale manufacturer of human cells, created from induced pluripotent stem cells, for use in basic research, drug discovery and regenerative medicine applications. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Cellular Dynamics International (United States), United States, covering academic research published from 2007 to 2023. Read More.


Open Access Percentage

60%


Total
Publications

107


Total Open
Publications

64


Total
Citations

5.6K


Open Access
Percentage

60%


Total
Publications

107


Total Open
Publications

64


Total
Citations

5.6K

Wikipedia

Website

download

Breakdown

20% 23% 17% 40%

Publisher Open

20%

Both

23%

Other Platform Open

17%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
20072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

14

Hybrid 39%

18

No Guarantees 30%

14

Other Platform Open

Domain 84%

36

Institution 21%

9

Public 16%

7

Other Internet 9%

4

Preprint 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
Europe PMC
Domain
34
Semantic Scholar
Public
7
Unknown Repository
Other Internet
4
University College London - UCL Discovery
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
2
Woods Hole Scientific Community - Open Access Server of the Woods Hole Scientific Community
Other Internet
1
University of Wollongong - Research Online
Institution
1
University of Melbourne - Minerva Access
Institution
1
1 / 2

Data updated 17 June 2024

Share

Share

Share